Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superior Laryngeal Nerve Block for Chronic Neurogenic Cough
NCT05292677Phase 4Unknown
- Sponsor
- Eastern Virginia Medical School
- Start
- Jul 2021
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide, bupivacaine in chronic cough, sponsored by Eastern Virginia Medical School. Status: unknown.
02
Drugs
triamcinolone acetonidebupivacaine
03
Conditions
chronic cough
Beyond the preview
Go deeper on NCT05292677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05292677.